These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29580806)

  • 1. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
    Li D; Wang H; Ding Y; Zhang Z; Zheng Z; Dong J; Kim H; Meng X; Zhou Q; Zhou J; Fang L; Shen Q
    Cancer Lett; 2018 Jun; 424():97-108. PubMed ID: 29580806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
    Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
    Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
    Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
    Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
    Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
    Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
    Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
    J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
    Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
    Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
    Teo CR; Casey PJ; Rasheed SA
    Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J; Gao P; Xu Y; Li Z
    Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: A preclinical study.
    Negi H; Merugu SB; Mangukiya HB; Li Z; Zhou B; Sehar Q; Kamle S; Yunus FU; Mashausi DS; Wu Z; Li D
    Cancer Lett; 2019 May; 449():125-134. PubMed ID: 30685412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
    Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
    Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
    BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
    Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB
    Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation.
    Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N
    Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
    Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
    Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies.
    Farahi A; Abedini MR; Javdani H; Arzi L; Chamani E; Farhoudi R; Talebloo N; Hoshyar R
    Mol Cell Biochem; 2021 Sep; 476(9):3341-3351. PubMed ID: 33929675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.